These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27325879)

  • 21. Good compounding practice for medicaments: a proposed plan for a community pharmacy.
    Marchetti M; Riccieri FM
    Farmaco Prat; 1978 Feb; 33(2):49-62. PubMed ID: 631313
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.
    Lobb WB; Wilkin NE; Holmes ER
    Int J Pharm Compd; 2015; 19(6):514-20. PubMed ID: 26891565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes.
    Isles M
    Int J Risk Saf Med; 2020; 31(3):133-144. PubMed ID: 32538874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and consistency of compounded oral liquid levothyroxine formulations.
    Meyer LM; Stephens K; Carter CA; Pickard W; Johnson PR; Eagerton DH
    J Am Pharm Assoc (2003); 2020; 60(6):e168-e172. PubMed ID: 32591200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional evaluation of community pharmacists' perceptions of intermediate care and medicines management across the healthcare interface.
    Millar A; Hughes C; Devlin M; Ryan C
    Int J Clin Pharm; 2016 Dec; 38(6):1380-1389. PubMed ID: 27655310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-centered care in the community-based compounding practice setting.
    McPherson T; Fontane P
    J Am Pharm Assoc (2003); 2010; 50(1):37-44. PubMed ID: 20097638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced diabetes credentials for the community pharmacist: A pilot study.
    Gonzalvo JD; Kruckeberg E; Newton ML; Chang E; Olenik NL; Gernant SA
    J Am Pharm Assoc (2003); 2016; 56(3):274-279.e3. PubMed ID: 27053278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-centered care as value-added service by compounding pharmacists.
    McPherson TB; Fontane PE; Day JR
    Int J Pharm Compd; 2013; 17(4):339-43. PubMed ID: 24261149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extemporaneous compounding activities and the associated informational needs of pharmacists.
    Crawford SY; Dombrowski SR
    Am J Hosp Pharm; 1991 Jun; 48(6):1205-10. PubMed ID: 1858798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Requirements regarding compounded pharmaceutical preparation].
    Neef CK
    Ned Tijdschr Geneeskd; 2010; 154():A2032. PubMed ID: 20858313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development.
    Orubu ES; Okwelogu C; Opanuga O; Nunn T; Tuleu C
    Health Policy Plan; 2017 Mar; 32(2):225-235. PubMed ID: 28207051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardizing i.v. infusion concentrations: National survey results.
    Phillips MS
    Am J Health Syst Pharm; 2011 Nov; 68(22):2176-82. PubMed ID: 22058104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytonadione oral liquid.
    Stumpf JL; Ciarkowski SL; Leja N; Jaynes EK
    Am J Health Syst Pharm; 2016 Jun; 73(12):858-61. PubMed ID: 27261231
    [No Abstract]   [Full Text] [Related]  

  • 37. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing entry-level competencies in sterile product preparation: an emerging challenge for pharmacy schools and experiential practice sites.
    Wuller WR; Kwasiborski CL
    Am J Health Syst Pharm; 2012 Jun; 69(12):1072-5. PubMed ID: 22644985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective survey of compounded medications for children in Japan.
    Saito J; Akabane M; Ishikawa Y; Iwahashi K; Nakamura H; Yamatani A
    Eur J Pharm Biopharm; 2020 Oct; 155():122-127. PubMed ID: 32853693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.